TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 1 January 3, 2013
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
ANNOUNCEMENTS
None Submitted for this issue.
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 1 January 3, 2013
(The next issue will be on January 15, 2013)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
ANNOUNCEMENTS
As we have done for the past few years, the individual PubMed "collections" of the papers appearing in each issue of TRIGGER for 2012 have now been consolidated into a single collection. (The individual PubMed collections for each TRIGGER issue in 2012 have, accordingly, been deleted.) Here are the links to the consolidated collections for the past four years:
2009 (301 references):
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1z_kd2hNzEEY8Wpxz8t1rph/
2010 (531references):
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1-cH907gHdg5lzzYz_yPkW5/
2011 (612 references):
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1bOQXIskFcJPXOjjcawlCfD/
2012 (976 references):
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/10m9tjGWs19M9UbjsWSGxO5/
_________________________________________________________
PAPERS IN PRESS2009 (301 references):
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1z_kd2hNzEEY8Wpxz8t1rph/
2010 (531references):
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1-cH907gHdg5lzzYz_yPkW5/
2011 (612 references):
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1bOQXIskFcJPXOjjcawlCfD/
2012 (976 references):
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/10m9tjGWs19M9UbjsWSGxO5/
_________________________________________________________
None Submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1Nm7pj_ByvHwRAApuHNWbiF/
Adam SS, Hoppe C (2012) Potential role for statins in sickle cell disease. Pediatr Blood Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/23281161
Adamzik M, Schafer S, Frey UH, Becker A, Kreuzer M, Winning S, . . .Hartmann M (2013) The NFKB1 Promoter Polymorphism (-94ins/delATTG) Alters Nuclear Translocation of NF-kappaB1 in Monocytes after Lipopolysaccharide Stimulation and Is Associated with Increased Mortality in Sepsis. Anesthesiology 118:123-133.
http://www.ncbi.nlm.nih.gov/pubmed/23249930
Agarwal V, Okonta KE, Lal PS (2012) Recombinant-activated factor VII in the paediatric cardiac surgery: Single unit experience. Afr J Paediatr Surg 9:193-197.
http://www.ncbi.nlm.nih.gov/pubmed/23250238
Alhumaidan HS, Cheves TA, Holme S, Sweeney JD, Md (2013) The effect of filtration on residual levels of coagulation factors in plasma. Am J Clin Pathol 139:110-116.
http://www.ncbi.nlm.nih.gov/pubmed/23270906
Anglin CO, Spence JS, Warner MA, Paliotta C, Harper C, Moore C, . . . Diaz-Arrastia R (2012) Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses. J Neurosurg.
http://www.ncbi.nlm.nih.gov/pubmed/23259827
Ayares D (2012) Multi-transgenic pigs for xenotransplantation. Reprod Fertil Dev 25:320.
http://www.ncbi.nlm.nih.gov/pubmed/23245178
Bansal D, Oberoi S, Marwaha RK, Singhi SC (2012) Approach to a Child with Bleeding in the Emergency Room. Indian J Pediatr.
http://www.ncbi.nlm.nih.gov/pubmed/23269640
Barbieri SS, Amadio P, Gianellini S, Tarantino E, Zacchi E, Veglia F, . . . Tremoli E (2012) Cyclooxygenase-2-derived prostacyclin regulates arterial thrombus formation by suppressing tissue factor in a sirtuin-1-dependent-manner. Circulation 126:1373-1384.
http://www.ncbi.nlm.nih.gov/pubmed/22865892
Ben-Hadj-Khalifa S, Lakhal B, Nsiri B, Mahjoub T, Almawi WY (2012) Factor VII levels, R353Q and -323P0/10 Factor VII variants, and the risk of acute coronary syndrome among Arab-African Tunisians. Mol Biol Rep.
http://www.ncbi.nlm.nih.gov/pubmed/23275237
Chan CM, Shorr AF, Perkins JG (2012) Factors associated with acute lung injury in combat casualties receiving massive blood transfusions: a retrospective analysis. J Crit Care 27:419 e417-414.
http://www.ncbi.nlm.nih.gov/pubmed/22227085
Chen YW, Chen IJ, Wang JS (2012) Absolute Hypoxic Exercise Training Enhances in vitro Thrombin Generation by Increasing Procoagulant Platelet-derived Microparticles under High Shear Stress in Sedentary Men. Clin Sci (Lond).
http://www.ncbi.nlm.nih.gov/pubmed/23252666
Chitalia V, Shivanna S, Martorell J, Balcells M, Bosch I, Kolandaivelu K, Edelman ER (2012) Uremic Serum and Solutes Increases Post Vascular Interventional Thrombotic Risk through Altered Stability of Smooth Muscle Cell Tissue Factor. Circulation.
http://www.ncbi.nlm.nih.gov/pubmed/23269489
Chou SH, Cai X, Konigsberg RG, Bresette LM, Henderson GV, Sorond FA, Feske SK (2012) Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case--control study. BMC Neurol 12:158.
http://www.ncbi.nlm.nih.gov/pubmed/23241423
Cimmino G, Conte S, Morello A, D'Elia S, Marchese V, Golino P (2012) The complex puzzle underlying the pathophysiology of acute coronary syndromes: from molecular basis to clinical manifestations. Expert Rev Cardiovasc Ther 10:1533-1543.
http://www.ncbi.nlm.nih.gov/pubmed/23253277
Darlington DN, Kheirabadi BS, Scherer MR, Martini WZ, Dubick MA (2012) Acidosis and correction of acidosis does not affect rFVIIa function in swine. Int J Burns Trauma 2:145-157.
http://www.ncbi.nlm.nih.gov/pubmed/23272296
de Paula EV, Kavakli K, Mahlangu J, Ayob Y, Lentz SR, Morfini M, . . . Chuansumrit A (2012) Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial. J Thromb Haemost 10:81-89.
http://www.ncbi.nlm.nih.gov/pubmed/22470921
Delabranche X, Berger A, Boisrame-Helms J, Meziani F (2012) Microparticles and infectious diseases. Med Mal Infect 42:335-343.
http://www.ncbi.nlm.nih.gov/pubmed/22766273
Ghasemzadeh M, Hosseini E (2012) Platelet-leukocyte crosstalk: Linking proinflammatory responses to procoagulant state. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23260445
Giansily-Blaizot M, Lopez E, Viart V, Chafa O, Tapon-Bretaudiere J, Claustres M, Taulan M (2012) Lethal factor VII deficiency due to novel mutations in the F7 promoter: functional analysis reveals disruption of HNF4 binding site. Thromb Haemost 108:277-283.
http://www.ncbi.nlm.nih.gov/pubmed/22628013
Gonzalez F, Kirwan JP, Rote NS, Minium J (2012) Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome. Am J Physiol Endocrinol Metab.
http://www.ncbi.nlm.nih.gov/pubmed/23249695
Goodwin JE, Feng Y, Velazquez H, Sessa WC (2012) Endothelial glucocorticoid receptor is required for protection against sepsis. Proc Natl Acad Sci U S A.
http://www.ncbi.nlm.nih.gov/pubmed/23248291
Gurion R, Siu A, Weiss AR, Masterson M (2012) Use of Recombinant Factor VIIa in a Pediatric Patient With Initial Presentation of Refractory Acute Immune Thrombocytopenic Purpura and Severe Bleeding. J Pediatr Pharmacol Ther 17:274-280.
http://www.ncbi.nlm.nih.gov/pubmed/23258971
Herse F, Lamarca B (2012) Angiotensin II Type 1 Receptor Autoantibody (AT1-AA)-Mediated Pregnancy Hypertension. Am J Reprod Immunol.
http://www.ncbi.nlm.nih.gov/pubmed/23279165
Holly P, Lisa L, Plamenova I, Dobrotova M, Kubisz P (2012) Recombinant activated factor VII as an additional agent in the management of bleeding in patients with chemotherapy-induced thrombocytopenia. Blood Transfus:1-4.
http://www.ncbi.nlm.nih.gov/pubmed/23245723
Hoving S, Heeneman S, Gijbels MJ, Te Poele JA, Visser N, Cleutjens J, . . . Stewart FA (2012) Irradiation induces different inflammatory and thrombotic responses in carotid arteries of wildtype C57BL/6J and atherosclerosis-prone ApoE(-/-) mice. Radiother Oncol 105:365-370.
http://www.ncbi.nlm.nih.gov/pubmed/23245647
Hu C, Huang L, Gest C, Xi X, Janin A, Soria C, . . . Lu H (2012) Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells. J Hematol Oncol 5:16.
http://www.ncbi.nlm.nih.gov/pubmed/22534171
Imashuku S, Kudo N, Kubo K, Saigo K, Okuno N, Tohyama K (2012) Rituximab for managing acquired hemophilia A in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation. J Blood Med 3:157-161.
http://www.ncbi.nlm.nih.gov/pubmed/23248577
Joseph B, Hadjizacharia P, Aziz H, Kulvatunyou N, Tang A, Pandit V, . . . Rhee P (2013) Prothrombin complex concentrate: An effective therapy in reversing the coagulopathy of traumatic brain injury. J Trauma Acute Care Surg 74:248-253.
http://www.ncbi.nlm.nih.gov/pubmed/23271101
Kalle M, Papareddy P, Kasetty G, Morgelin M, van der Plas MJ, Rydengard V, . . . Schmidtchen A (2012) Host Defense Peptides of Thrombin Modulate Inflammation and Coagulation in Endotoxin-Mediated Shock and Pseudomonas aeruginosa Sepsis. PLoS One 7:e51313.
http://www.ncbi.nlm.nih.gov/pubmed/23272096
Keller MK, Pruss A, Sander M, Spies C, Schoenfeld H, Schuster M, . . . Von Heymann C (2012) Thawed solvent/detergent-treated plasma: too precious to be wasted after 6 hours? Blood Transfus 10:360-367.
http://www.ncbi.nlm.nih.gov/pubmed/22507858
Kortchinsky T, Vigue B, Samama CM (2012) [Reversal for heparins and new anticoagulant treatments.]. Ann Fr Anesth Reanim.
http://www.ncbi.nlm.nih.gov/pubmed/23273505
Laguna P, Mital A (2012) Single higher dose of recombinant activated factor VII in the treatment of hemorrhages in patients with hemophilia complicated by inhibitors. Adv Clin Exp Med 21:519-524.
http://www.ncbi.nlm.nih.gov/pubmed/23240458
Langstrom S, Peltola V, Petaja J, Ruuskanen O, Heikinheimo M (2012) Enhanced thrombin generation and depressed anticoagulant function in children with pneumonia. Acta Paediatr 101:919-923.
http://www.ncbi.nlm.nih.gov/pubmed/22646857
Li H, Tian ML, Yu G, Liu YC, Wang X, Zhang J, . . . Tang JQ (2012) Hyperthermia synergizes with tissue factor knockdown to suppress the growth and hepatic metastasis of colorectal cancer in orthotopic tumor model. J Surg Oncol 106:689-695.
http://www.ncbi.nlm.nih.gov/pubmed/22532129
Mackman N (2012) Uremic Serum and Ubiquitylation of Tissue Factor. Circulation.
http://www.ncbi.nlm.nih.gov/pubmed/23269490
Martinez Lopez MC, Alcaraz Romero AJ, Martinez Lopez AB, Fernandez-Llamazares CM, Ramos Navarro C (2012) [Risk assessment of thrombotic events after the use of activated factor vii.]. An Pediatr (Barc).
http://www.ncbi.nlm.nih.gov/pubmed/23265723
Morrissey JH (2012) The many domains of TFPI. Thromb Haemost 108:206.
http://www.ncbi.nlm.nih.gov/pubmed/22782428
Ohkubo YZ, Pogorelov TV, Arcario MJ, Christensen GA, Tajkhorshid E (2012) Accelerating membrane insertion of peripheral proteins with a novel membrane mimetic model. Biophys J 102:2130-2139.
http://www.ncbi.nlm.nih.gov/pubmed/22824277
Ovstebo R, Aass HC, Haug KB, Troseid AM, Gopinathan U, Kierulf P, . . . Henriksson CE (2012) LPS from Neisseria meningitidis is crucial for inducing monocyte- and microparticle-associated tissue factor activity but not for tissue factor expression. Innate Immun 18:580-591.
http://www.ncbi.nlm.nih.gov/pubmed/22180561
Peraramelli S, Suylen DP, Rosing J, Hackeng TM (2012) The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa. Thromb Haemost 108:266-276.
http://www.ncbi.nlm.nih.gov/pubmed/22627666
Sakowicz A, Fendler W, Lelonek M, Sakowicz B, Pietrucha T (2012) Genetic Polymorphisms and the Risk of Myocardial Infarction in Patients Under 45 Years of Age. Biochem Genet.
http://www.ncbi.nlm.nih.gov/pubmed/23274712
Sanborn MR, Thom SR, Bohman LE, Stein SC, Levine JM, Milovanova T, . . . Kumar MA (2012) Temporal dynamics of microparticle elevation following subarachnoid hemorrhage. J Neurosurg 117:579-586.
http://www.ncbi.nlm.nih.gov/pubmed/22794324
Sarial S, Asadi F, Jeddi-Tehrani M, Hadavi R, Bayat AA, Mahmoudian J, . . . Rabbani H (2012) A High Affinity Monoclonal Antibody Recognizing the Light Chain of Human Coagulating Factor VII.
Hybridoma (Larchmt) 31:443-448.
http://www.ncbi.nlm.nih.gov/pubmed/23244324
Shi W, Mei H, Deng J, Chen C, Wang H, Guo T, . . . Hu Y (2012) A tissue factor targeted nanomedical system for thrombi-specific drug delivery. Biomaterials 33:7643-7654.
http://www.ncbi.nlm.nih.gov/pubmed/22819496
Starr ME, Hu Y, Stromberg AJ, Carmical JR, Wood TG, Evers BM, Saito H (2012) Gene expression profile of mouse white adipose tissue during inflammatory stress: age-dependent upregulation of major pro-coagulant factors. Aging Cell.
http://www.ncbi.nlm.nih.gov/pubmed/23279636
Tang YL, Zhou Y, Wang CB, Qin Y, Feng J, Qin J (2012) [Predictive value of tissue factor-associated platelet microparticles in thrombosis of patients with lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 20:325-328.
http://www.ncbi.nlm.nih.gov/pubmed/22541091
Tangelder M, Long C, Emmerechts J, Jacquemin M, Peerlinck K, Vanassche T, . . . Verhamme P (2012) Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of factor VIII. J Thromb Haemost 10:1371-1378.
http://www.ncbi.nlm.nih.gov/pubmed/22540161
Thaler J, Ay C, Mackman N, Bertina RM, Kaider A, Marosi C, . . . Pabinger I (2012) Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J Thromb Haemost 10:1363-1370.
http://www.ncbi.nlm.nih.gov/pubmed/22520016
van den Hengel LG, van den Berg YW, Reitsma PH, Bos MH, Versteeg HH (2012) Evolutionary conservation of the tissue factor disulfide bonds and identification of a possible oxidoreductase binding motif. J Thromb Haemost 10:161-162.
http://www.ncbi.nlm.nih.gov/pubmed/22066736
van den Hengel LG, van Steijn-van Tol AQ, Bertina RM, Versteeg HH, Osanto S (2012) Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23260444
Van Der Meijden PE, Van Schilfgaarde M, Van Oerle R, Renne T, ten Cate H, Spronk HM (2012) Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. J Thromb Haemost 10:1355-1362.
http://www.ncbi.nlm.nih.gov/pubmed/22537188
Wang CH, Chen YC, Tsao CW, Yang SS (2012) Dalteparin-associated catastrophic retroperitoneal hematoma successfully treated with recombinant factor VIIa. Int Urol Nephrol 44:1091-1095.
http://www.ncbi.nlm.nih.gov/pubmed/22180040
Winnik S, Stein S, Matter CM (2012) SIRT1 - An Anti-Inflammatory Pathway at the Crossroads Between Metabolic Disease and Atherosclerosis. Curr Vasc Pharmacol 10:693-696.
http://www.ncbi.nlm.nih.gov/pubmed/23259556
Yang Y, Yan FZ, Yan JS, Zhao J, Li WP, Chen XY, . . . Rao SM (2011) [Screening drugs for regulating tissue factor gene expression]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 19:207-210.
http://www.ncbi.nlm.nih.gov/pubmed/21362253
Zhang Q, Liu X, Xu S, Li C, Zhang Y, Yang J, Zheng J (2012) Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer. Cancer Biother Radiopharm 27:384-391.
http://www.ncbi.nlm.nih.gov/pubmed/22651685
Zwicker JI, Liebman HA, Bauer KA, Caughey T, Campigotto F, Rosovsky R, . . . Furie B (2012) Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study). Br J Haematol.
http://www.ncbi.nlm.nih.gov/pubmed/23240761
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1Nm7pj_ByvHwRAApuHNWbiF/
Adam SS, Hoppe C (2012) Potential role for statins in sickle cell disease. Pediatr Blood Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/23281161
Adamzik M, Schafer S, Frey UH, Becker A, Kreuzer M, Winning S, . . .Hartmann M (2013) The NFKB1 Promoter Polymorphism (-94ins/delATTG) Alters Nuclear Translocation of NF-kappaB1 in Monocytes after Lipopolysaccharide Stimulation and Is Associated with Increased Mortality in Sepsis. Anesthesiology 118:123-133.
http://www.ncbi.nlm.nih.gov/pubmed/23249930
Agarwal V, Okonta KE, Lal PS (2012) Recombinant-activated factor VII in the paediatric cardiac surgery: Single unit experience. Afr J Paediatr Surg 9:193-197.
http://www.ncbi.nlm.nih.gov/pubmed/23250238
Alhumaidan HS, Cheves TA, Holme S, Sweeney JD, Md (2013) The effect of filtration on residual levels of coagulation factors in plasma. Am J Clin Pathol 139:110-116.
http://www.ncbi.nlm.nih.gov/pubmed/23270906
Anglin CO, Spence JS, Warner MA, Paliotta C, Harper C, Moore C, . . . Diaz-Arrastia R (2012) Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses. J Neurosurg.
http://www.ncbi.nlm.nih.gov/pubmed/23259827
Ayares D (2012) Multi-transgenic pigs for xenotransplantation. Reprod Fertil Dev 25:320.
http://www.ncbi.nlm.nih.gov/pubmed/23245178
Bansal D, Oberoi S, Marwaha RK, Singhi SC (2012) Approach to a Child with Bleeding in the Emergency Room. Indian J Pediatr.
http://www.ncbi.nlm.nih.gov/pubmed/23269640
Barbieri SS, Amadio P, Gianellini S, Tarantino E, Zacchi E, Veglia F, . . . Tremoli E (2012) Cyclooxygenase-2-derived prostacyclin regulates arterial thrombus formation by suppressing tissue factor in a sirtuin-1-dependent-manner. Circulation 126:1373-1384.
http://www.ncbi.nlm.nih.gov/pubmed/22865892
Ben-Hadj-Khalifa S, Lakhal B, Nsiri B, Mahjoub T, Almawi WY (2012) Factor VII levels, R353Q and -323P0/10 Factor VII variants, and the risk of acute coronary syndrome among Arab-African Tunisians. Mol Biol Rep.
http://www.ncbi.nlm.nih.gov/pubmed/23275237
Chan CM, Shorr AF, Perkins JG (2012) Factors associated with acute lung injury in combat casualties receiving massive blood transfusions: a retrospective analysis. J Crit Care 27:419 e417-414.
http://www.ncbi.nlm.nih.gov/pubmed/22227085
Chen YW, Chen IJ, Wang JS (2012) Absolute Hypoxic Exercise Training Enhances in vitro Thrombin Generation by Increasing Procoagulant Platelet-derived Microparticles under High Shear Stress in Sedentary Men. Clin Sci (Lond).
http://www.ncbi.nlm.nih.gov/pubmed/23252666
Chitalia V, Shivanna S, Martorell J, Balcells M, Bosch I, Kolandaivelu K, Edelman ER (2012) Uremic Serum and Solutes Increases Post Vascular Interventional Thrombotic Risk through Altered Stability of Smooth Muscle Cell Tissue Factor. Circulation.
http://www.ncbi.nlm.nih.gov/pubmed/23269489
Chou SH, Cai X, Konigsberg RG, Bresette LM, Henderson GV, Sorond FA, Feske SK (2012) Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case--control study. BMC Neurol 12:158.
http://www.ncbi.nlm.nih.gov/pubmed/23241423
Cimmino G, Conte S, Morello A, D'Elia S, Marchese V, Golino P (2012) The complex puzzle underlying the pathophysiology of acute coronary syndromes: from molecular basis to clinical manifestations. Expert Rev Cardiovasc Ther 10:1533-1543.
http://www.ncbi.nlm.nih.gov/pubmed/23253277
Darlington DN, Kheirabadi BS, Scherer MR, Martini WZ, Dubick MA (2012) Acidosis and correction of acidosis does not affect rFVIIa function in swine. Int J Burns Trauma 2:145-157.
http://www.ncbi.nlm.nih.gov/pubmed/23272296
de Paula EV, Kavakli K, Mahlangu J, Ayob Y, Lentz SR, Morfini M, . . . Chuansumrit A (2012) Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial. J Thromb Haemost 10:81-89.
http://www.ncbi.nlm.nih.gov/pubmed/22470921
Delabranche X, Berger A, Boisrame-Helms J, Meziani F (2012) Microparticles and infectious diseases. Med Mal Infect 42:335-343.
http://www.ncbi.nlm.nih.gov/pubmed/22766273
Ghasemzadeh M, Hosseini E (2012) Platelet-leukocyte crosstalk: Linking proinflammatory responses to procoagulant state. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23260445
Giansily-Blaizot M, Lopez E, Viart V, Chafa O, Tapon-Bretaudiere J, Claustres M, Taulan M (2012) Lethal factor VII deficiency due to novel mutations in the F7 promoter: functional analysis reveals disruption of HNF4 binding site. Thromb Haemost 108:277-283.
http://www.ncbi.nlm.nih.gov/pubmed/22628013
Gonzalez F, Kirwan JP, Rote NS, Minium J (2012) Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome. Am J Physiol Endocrinol Metab.
http://www.ncbi.nlm.nih.gov/pubmed/23249695
Goodwin JE, Feng Y, Velazquez H, Sessa WC (2012) Endothelial glucocorticoid receptor is required for protection against sepsis. Proc Natl Acad Sci U S A.
http://www.ncbi.nlm.nih.gov/pubmed/23248291
Gurion R, Siu A, Weiss AR, Masterson M (2012) Use of Recombinant Factor VIIa in a Pediatric Patient With Initial Presentation of Refractory Acute Immune Thrombocytopenic Purpura and Severe Bleeding. J Pediatr Pharmacol Ther 17:274-280.
http://www.ncbi.nlm.nih.gov/pubmed/23258971
Herse F, Lamarca B (2012) Angiotensin II Type 1 Receptor Autoantibody (AT1-AA)-Mediated Pregnancy Hypertension. Am J Reprod Immunol.
http://www.ncbi.nlm.nih.gov/pubmed/23279165
Holly P, Lisa L, Plamenova I, Dobrotova M, Kubisz P (2012) Recombinant activated factor VII as an additional agent in the management of bleeding in patients with chemotherapy-induced thrombocytopenia. Blood Transfus:1-4.
http://www.ncbi.nlm.nih.gov/pubmed/23245723
Hoving S, Heeneman S, Gijbels MJ, Te Poele JA, Visser N, Cleutjens J, . . . Stewart FA (2012) Irradiation induces different inflammatory and thrombotic responses in carotid arteries of wildtype C57BL/6J and atherosclerosis-prone ApoE(-/-) mice. Radiother Oncol 105:365-370.
http://www.ncbi.nlm.nih.gov/pubmed/23245647
Hu C, Huang L, Gest C, Xi X, Janin A, Soria C, . . . Lu H (2012) Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells. J Hematol Oncol 5:16.
http://www.ncbi.nlm.nih.gov/pubmed/22534171
Imashuku S, Kudo N, Kubo K, Saigo K, Okuno N, Tohyama K (2012) Rituximab for managing acquired hemophilia A in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation. J Blood Med 3:157-161.
http://www.ncbi.nlm.nih.gov/pubmed/23248577
Joseph B, Hadjizacharia P, Aziz H, Kulvatunyou N, Tang A, Pandit V, . . . Rhee P (2013) Prothrombin complex concentrate: An effective therapy in reversing the coagulopathy of traumatic brain injury. J Trauma Acute Care Surg 74:248-253.
http://www.ncbi.nlm.nih.gov/pubmed/23271101
Kalle M, Papareddy P, Kasetty G, Morgelin M, van der Plas MJ, Rydengard V, . . . Schmidtchen A (2012) Host Defense Peptides of Thrombin Modulate Inflammation and Coagulation in Endotoxin-Mediated Shock and Pseudomonas aeruginosa Sepsis. PLoS One 7:e51313.
http://www.ncbi.nlm.nih.gov/pubmed/23272096
Keller MK, Pruss A, Sander M, Spies C, Schoenfeld H, Schuster M, . . . Von Heymann C (2012) Thawed solvent/detergent-treated plasma: too precious to be wasted after 6 hours? Blood Transfus 10:360-367.
http://www.ncbi.nlm.nih.gov/pubmed/22507858
Kortchinsky T, Vigue B, Samama CM (2012) [Reversal for heparins and new anticoagulant treatments.]. Ann Fr Anesth Reanim.
http://www.ncbi.nlm.nih.gov/pubmed/23273505
Laguna P, Mital A (2012) Single higher dose of recombinant activated factor VII in the treatment of hemorrhages in patients with hemophilia complicated by inhibitors. Adv Clin Exp Med 21:519-524.
http://www.ncbi.nlm.nih.gov/pubmed/23240458
Langstrom S, Peltola V, Petaja J, Ruuskanen O, Heikinheimo M (2012) Enhanced thrombin generation and depressed anticoagulant function in children with pneumonia. Acta Paediatr 101:919-923.
http://www.ncbi.nlm.nih.gov/pubmed/22646857
Li H, Tian ML, Yu G, Liu YC, Wang X, Zhang J, . . . Tang JQ (2012) Hyperthermia synergizes with tissue factor knockdown to suppress the growth and hepatic metastasis of colorectal cancer in orthotopic tumor model. J Surg Oncol 106:689-695.
http://www.ncbi.nlm.nih.gov/pubmed/22532129
Mackman N (2012) Uremic Serum and Ubiquitylation of Tissue Factor. Circulation.
http://www.ncbi.nlm.nih.gov/pubmed/23269490
Martinez Lopez MC, Alcaraz Romero AJ, Martinez Lopez AB, Fernandez-Llamazares CM, Ramos Navarro C (2012) [Risk assessment of thrombotic events after the use of activated factor vii.]. An Pediatr (Barc).
http://www.ncbi.nlm.nih.gov/pubmed/23265723
Morrissey JH (2012) The many domains of TFPI. Thromb Haemost 108:206.
http://www.ncbi.nlm.nih.gov/pubmed/22782428
Ohkubo YZ, Pogorelov TV, Arcario MJ, Christensen GA, Tajkhorshid E (2012) Accelerating membrane insertion of peripheral proteins with a novel membrane mimetic model. Biophys J 102:2130-2139.
http://www.ncbi.nlm.nih.gov/pubmed/22824277
Ovstebo R, Aass HC, Haug KB, Troseid AM, Gopinathan U, Kierulf P, . . . Henriksson CE (2012) LPS from Neisseria meningitidis is crucial for inducing monocyte- and microparticle-associated tissue factor activity but not for tissue factor expression. Innate Immun 18:580-591.
http://www.ncbi.nlm.nih.gov/pubmed/22180561
Peraramelli S, Suylen DP, Rosing J, Hackeng TM (2012) The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa. Thromb Haemost 108:266-276.
http://www.ncbi.nlm.nih.gov/pubmed/22627666
Sakowicz A, Fendler W, Lelonek M, Sakowicz B, Pietrucha T (2012) Genetic Polymorphisms and the Risk of Myocardial Infarction in Patients Under 45 Years of Age. Biochem Genet.
http://www.ncbi.nlm.nih.gov/pubmed/23274712
Sanborn MR, Thom SR, Bohman LE, Stein SC, Levine JM, Milovanova T, . . . Kumar MA (2012) Temporal dynamics of microparticle elevation following subarachnoid hemorrhage. J Neurosurg 117:579-586.
http://www.ncbi.nlm.nih.gov/pubmed/22794324
Sarial S, Asadi F, Jeddi-Tehrani M, Hadavi R, Bayat AA, Mahmoudian J, . . . Rabbani H (2012) A High Affinity Monoclonal Antibody Recognizing the Light Chain of Human Coagulating Factor VII.
Hybridoma (Larchmt) 31:443-448.
http://www.ncbi.nlm.nih.gov/pubmed/23244324
Shi W, Mei H, Deng J, Chen C, Wang H, Guo T, . . . Hu Y (2012) A tissue factor targeted nanomedical system for thrombi-specific drug delivery. Biomaterials 33:7643-7654.
http://www.ncbi.nlm.nih.gov/pubmed/22819496
Starr ME, Hu Y, Stromberg AJ, Carmical JR, Wood TG, Evers BM, Saito H (2012) Gene expression profile of mouse white adipose tissue during inflammatory stress: age-dependent upregulation of major pro-coagulant factors. Aging Cell.
http://www.ncbi.nlm.nih.gov/pubmed/23279636
Tang YL, Zhou Y, Wang CB, Qin Y, Feng J, Qin J (2012) [Predictive value of tissue factor-associated platelet microparticles in thrombosis of patients with lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 20:325-328.
http://www.ncbi.nlm.nih.gov/pubmed/22541091
Tangelder M, Long C, Emmerechts J, Jacquemin M, Peerlinck K, Vanassche T, . . . Verhamme P (2012) Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of factor VIII. J Thromb Haemost 10:1371-1378.
http://www.ncbi.nlm.nih.gov/pubmed/22540161
Thaler J, Ay C, Mackman N, Bertina RM, Kaider A, Marosi C, . . . Pabinger I (2012) Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J Thromb Haemost 10:1363-1370.
http://www.ncbi.nlm.nih.gov/pubmed/22520016
van den Hengel LG, van den Berg YW, Reitsma PH, Bos MH, Versteeg HH (2012) Evolutionary conservation of the tissue factor disulfide bonds and identification of a possible oxidoreductase binding motif. J Thromb Haemost 10:161-162.
http://www.ncbi.nlm.nih.gov/pubmed/22066736
van den Hengel LG, van Steijn-van Tol AQ, Bertina RM, Versteeg HH, Osanto S (2012) Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23260444
Van Der Meijden PE, Van Schilfgaarde M, Van Oerle R, Renne T, ten Cate H, Spronk HM (2012) Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. J Thromb Haemost 10:1355-1362.
http://www.ncbi.nlm.nih.gov/pubmed/22537188
Wang CH, Chen YC, Tsao CW, Yang SS (2012) Dalteparin-associated catastrophic retroperitoneal hematoma successfully treated with recombinant factor VIIa. Int Urol Nephrol 44:1091-1095.
http://www.ncbi.nlm.nih.gov/pubmed/22180040
Winnik S, Stein S, Matter CM (2012) SIRT1 - An Anti-Inflammatory Pathway at the Crossroads Between Metabolic Disease and Atherosclerosis. Curr Vasc Pharmacol 10:693-696.
http://www.ncbi.nlm.nih.gov/pubmed/23259556
Yang Y, Yan FZ, Yan JS, Zhao J, Li WP, Chen XY, . . . Rao SM (2011) [Screening drugs for regulating tissue factor gene expression]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 19:207-210.
http://www.ncbi.nlm.nih.gov/pubmed/21362253
Zhang Q, Liu X, Xu S, Li C, Zhang Y, Yang J, Zheng J (2012) Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer. Cancer Biother Radiopharm 27:384-391.
http://www.ncbi.nlm.nih.gov/pubmed/22651685
Zwicker JI, Liebman HA, Bauer KA, Caughey T, Campigotto F, Rosovsky R, . . . Furie B (2012) Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study). Br J Haematol.
http://www.ncbi.nlm.nih.gov/pubmed/23240761
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
